A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed fat-burning effects. Followers are urged to contact these profiles directly for source information, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Additionally, a robust market exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the drug there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals administering substances of unknown origin.
Several experts said the demand for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or imprisonment.
Service Response and Content Removal
Based on the social media company, the service has removed violative content and prohibited related hashtags and search suggestions. The organization stated it was committed to maintaining the service safe and allocating resources in strengthening compliance measures.
Online Marketplace Operations
Research also discovered communities with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with numerous of users, filled with images of slimming results, glowing reviews and step-by-step guides for mixing or administering at residence.
Within minutes of entering one group, a seller shared WhatsApp details, where most transactions occur. The seller sent an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about body mass, medical conditions or previous experience.
Item Information and Pricing
Within these groups, messages display black plastic packages with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with sterile water, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service said it regularly monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they can’t verify. Even if the science behind retatrutide is valid, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.
Her team has already encountered patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”
Producer Statement
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject users to potentially significant medical dangers”.
